Topic: Disease/vaccine specific information
Total results with these characteristics: 996
- Diarrheal Disease: Solutions to Defeat a Global Killer
Diarrheal Disease: Solutions to Defeat a Global Killer presents scientific evidence to support strategies to scale up use of interventions, including safe water, improved sanitation and hygiene, breastfeeding and optimal complementary feeding, …
- Diarrhoea: Why Children Are Still Dying and What Can Be Done
This joint report from the World Health Organization and the United Nations Children's Fund (UNICEF) focuses attention on the prevention and management of diarrheal diseases. It examines the latest available information on the burden of childhood …
Author: World Health Organization, United Nations Children's Fund
- Diarrhoea-Related Hospitalizations in Children Before and After Implementation of Monovalent Rotavirus Vaccination in Mexico
This article, published in the Bulletin of the World Health Organization, reports on a study that compared the incidence of diarrhea in young children before and after the national introduction of monovalent rotavirus vaccine in Mexico. The results …
Author: Esparza-Aguilar M, Gastañaduy PA, Sánchez-Uribe E, et al.
- Direct and Indirect Effects of Rotavirus Vaccination Upon Childhood Hospitalizations in 3 US Counties, 2006–2009
This article, published in Clinical Infectious Diseases, is about an active, population-based surveillance for rotavirus gastroenteritis hospitalizations in three United States counties to assess the impact of rotavirus vaccines. The study …
Author: Payne DC, Staat MA, Edwards KM, et al.
- Disease Burden Due to Enterotoxigenic Escherichia coli (ETEC) in the First Two Years of Life in an Urban Community in Bangladesh
Published in Infection and Immunity, a cohort of 321 children were followed from birth up to two years to determine the incidence of enterotoxigenic Escherichia coli (ETEC) in Bangladesh. Children with ETEC diarrhea were underweight and stunted …
Author: Qadri F, Saha A, Ahmed T
- Disease Outbreak News
This web page provides frequently updated information about current disease outbreaks, as well as disease-specific archives of past alerts and links to related resources.
Author: World Health Organization
- Diseases and the Vaccines That Prevent Them
This series of fact sheets describes symptoms of infection as well as the benefits and risk of vaccination for 14 diseases, including hepatitis B, Haemophilus influenzae type b, influenza, pneumococcal disease, polio, and rotavirus. There …
Author: US Centers for Disease Control and Prevention
- Dissociation Between Serum Neutralizing and Glycoprotein Antibody Responses of Infants and Children Who Received Inactivated Respiratory Syncytial Virus Vaccine
In the 1960s a respiratory syncytial virus (RSV) vaccine was evaluated in infants and young children. Vaccinees who received formalin-inactivated RSV during early infancy developed more serious lower-respiratory-tract disease when infected with the …
Author: Murphy BR, Prince GA, Walsh EE, et al.
- Distribution of Rotavirus Genotypes in Europe, 2004-2005: The REVEAL Study
Rotavirus genotypes were identified in several European countries using ELISA tests, and investigators determined that G1–G4 and G9 genotypes were responsible for the majority of cases. Citing these results, the authors suggest that rotavirus …
Author: Van Damme P, Giaquinto C, Maxwell M, Todd P, Van der Wielen M
- Distributional Impact of Rotavirus Vaccination in 25 GAVI Countries: Estimating Disparities in Benefits and Cost-Effectiveness
This article, published in Vaccine, reports on an analysis that combines the results of a country-level model of rotavirus vaccination published elsewhere with data from Demographic and Health Surveys on within-country patterns of vaccine coverage …
Author: Rheingans R, Atherly D, Anderson J
- DNA Vaccines Expressing Pneumococcal Surface Protein A (PspA) Elicit Protection Levels Comparable to Recombinant Protein
This article, published in the Journal of Medical Microbiology, provide results that show that DNA vaccines expressing PspA are able to elicit protection levels comparable to recombinant protein, even though total anti-PspA IgG response is …
Author: Ferreira DM, Miyaji EN, Oliveira MLS, et al.
- A Dose-Escalation Safety and Immunogenicity Study of Live Attenuated Oral Rotavirus Vaccine 116E in Infants: A Randomized, Double-Blind, Placebo-Controlled Trial
This study, published in the Journal of Infectious Diseases, tested the neonatal rotavirus candidate vaccine 116E in a double-blind, placebo-controlled dose-escalation trial in India. Two doses of the Vero cell-adapted vaccine were evaluated in …
Author: Bhandari N, Sharma P, Taneja S, et al.
- Duration of Protection of Pentavalent Rotavirus Vaccination in Nicaragua
This article, published in Pediatrics, summarizes a case-control study conducted at four hospitals in Nicaragua to evaluate the duration of protection after rotavirus vaccination among eligible infants. The pentavalent rotavirus vaccine …
Author: Patel M, Pedreira C, De Oliveira LH, et al.
- Dynamic Models of Meningococcal Carriage, Disease, and the Impact of Serogroup C Conjugate Vaccination
The authors of this article, published in The American Journal of Epidemiology, use data on immunization with serogroup C meningococcal conjugate vaccines in England and Wales to develop and apply a mathematical model that investigates the …
Author: Trotter CL, Gay NJ, Edmunds WJ
- Economic Costs of Rotavirus Gastroenteritis and Cost-Effectiveness of Vaccination in Developing Countries
This article, published in The Journal of Infectious Diseases, evaluated the economic burden of rotavirus and the cost-effectiveness of vaccination from the health care perspective. The authors found that rotavirus vaccination would annually prevent …
Author: Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD
- Economic Evaluation of Delivering Haemophilus influenzae type b Vaccine in Routine Immunization Services in Kenya
This study, published in Bulletin of the World Health Organization, discusses the introduction of Hib vaccine in Kenya, one of the first nine countries to receive financial support from GAVI for Hib vaccine introduction. The objective of this study …
Author: Oloo Akumu A, Englisha M, Scott JAG, Griffiths UK
- Economic Evaluation of Haemophilus influenzae type b Vaccination in Indonesia: A Cost-Effectiveness Analysis
This paper, published in the Journal of Public Health, evaluates the cost-effectiveness of introducing Hib vaccine in Indonesia as an addition to the country's current DTP–Hepatitis B vaccination program.
Author: Broughton E
- Economic Evaluations of Rotavirus Immunization for Developing Countries: A Review of the Literature
This article, published in Expert Review of Vaccines, analyzes the cost-effectiveness of universal rotavirus immunization in developing countries. The authors identified and evaluated 15 cost-effectiveness studies conducted in the developing world. …
Author: Tu HA, Woerdenbag HJ, Kane S, Rozenbaum MH, Li SC, Postma MJ
- Economic Impact of a Rotavirus Vaccination Program in Mexico
This article, published in the Pan American Journal of Public Health, examines a national rotavirus vaccination program in Mexico and evaluates its costs and benefits. The article concludes that the program would be highly cost-effective and …
Author: Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y
- Effect of a Conjugate Pneumococcal Vaccine on the Occurrence of Respiratory Infections and Antibiotic Use in Day-Care Center Attendees
Published in the Pediatric Infectious Disease Journal, this article examines whether the use of a pneumococcal conjugate vaccine could reduce the occurrence of respiratory infections and the ensuing antibiotic drug use in the day care. In this …
Author: Dagan R, Sikuler-Cohen M, Zamir O, et al.
- Effect of a Serogroup A Meningococcal Conjugate Vaccine (PsA—TT) on Serogroup A Meningococcal Meningitis and Carriage in Chad: A Community Study
A serogroup A meningococcal polysaccharide—tetanus toxoid conjugate vaccine (PsA—TT, MenAfriVac) was licensed in India in 2009, and prequalified by the World Health Organization in 2010, on the basis of its safety and immunogenicity. This …
Author: Daugla DM, Gami JP, Gamougam K, et al.
- Effect of Combined Pneumococcal Conjugate and Polysaccharide Vaccination on Recurrent Otitis Media with Effusion
Published in the journal Pediatrics, this article assess the effect of combined pneumococcal conjugate and polysaccharide vaccinations on the recurrence of otitis media through a randomised, controlled trial.
Author: van Heerbeek N, Straetemans M, Wiertsema SP
- Effect of Human Rotavirus Vaccine on Severe Diarrhea in African Infants
This article, published in The New England Journal of Medicine, discusses a study on the efficacy of rotavirus vaccine in Africa. Results showed 30.2 percent efficacy against all-cause severe gastroenteritis. The study concluded that rotavirus …
Author: Madhi SA, Cunliffe NA, Steele D, et al.
- Effect of Multiple, Simultaneous Vaccines on Polio Seroresponse and Associated Health Outcomes
This article, published in Vaccine, compared vaccination with inactivated polio vaccine (IPV) alone or simultaneously with one other vaccine to vaccination with IPV and four other vaccines among adults in the United States military. The results …
Author: Broderick MP, Oberste MS, Moore D, Romero-Steiner S, Hansen CJ, Faix DJ
- Effect of Rotavirus Vaccination on Death From Childhood Diarrhea in Mexico
This article, published in The New England Journal of Medicine, discusses a study on the effectiveness of rotavirus vaccine in Mexico. The study examined the impact of vaccination on diarrheal deaths in Mexican children between 2008 and 2009 …
Author: Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, et al.